EMAIL THIS PAGE TO A FRIEND

Bioorganic & medicinal chemistry letters

Antitumor agents. Part 3: synthesis and cytotoxicity of new trans-stilbene benzenesulfonamide derivatives.


PMID 11909706

Abstract

A new series of trans-stilbene benzenesulfonamide derivatives were designed and synthesized as potential antitumor agents. These new compounds were evaluated in the National Cancer Institute's 60 human tumor cell line in vitro screen. Compounds 9-13 were cytotoxic against several cell lines. Notably, two compounds, 9 and 12, demonstrated selective cytotoxic activity against BT-549 breast cancer (GI(50)=0.205 microM) and HT-29 colon cancer (GI(50)=0.554 microM), respectively.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

308323
cis-Stilbene oxide, 97%
C14H12O
S4921
trans-Stilbene oxide, 98%
C14H12O